FRIEDMAN CATHY has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 130000 shares of Lyell Immunopharma, Inc. ($LYEL) on May 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lyell Immunopharma, Inc. | $LYEL | FRIEDMAN CATHY | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| June 14, 2024 | Lyell Immunopharma, Inc. | $LYEL | FRIEDMAN CATHY | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Lyell Immunopharma, Inc. | $LYEL | FRIEDMAN CATHY | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Lyell Immunopharma, Inc. | $LYEL | FRIEDMAN CATHY | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |